Schizophrenia Research
Volume 122, Issue 1 , Pages 38-42 , September 2010

Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data

  • Peilin Jia

      Affiliations

    • Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • Department of Psychiatry, Vanderbilt University, Nashville, TN 37232, USA
    • ,
  • Lily Wang

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • ,
  • Herbert Y. Meltzer

      Affiliations

    • Department of Psychiatry, Vanderbilt University, Nashville, TN 37232, USA
    • ,
  • Zhongming Zhao

      Affiliations

    • Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
    • Department of Psychiatry, Vanderbilt University, Nashville, TN 37232, USA
    • Corresponding Author InformationCorresponding author. Department of Biomedical Informatics, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA. Tel.: +1 615 343 9158; fax: +1 615 936 8545.

Received 18 April 2010 ,Revised 26 June 2010 ,Accepted 1 July 2010.

References 

  1. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, et al. Control of synaptic strength by glial TNFalpha. Science. 2002;295:2282–2285
  2. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Method. 1995;57:289–300
  3. Dinu I, Potter JD, Mueller T, Liu Q, Adewale AJ, Jhangri GS, et al. Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics. 2007;8:242
  4. Efron B, Tibshirani R. On testing the significance of sets of genes. Ann. Appl. Stat. 2007;1:107–129
  5. Fisher RA. Statistical methods for research workers. London: Oliver and Boyd; 1932;
  6. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. The dystrobrevin-binding protein 1 gene: features and networks. Mol. Psychiatry. 2009;14:18–29
  7. Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, et al. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc. Natl Acad. Sci. USA. 2007;104:16621–16626
  8. Holmans P, Green EK, Pahwa JS, Ferreira MA, Purcell SM, Sklar P, et al. Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 2009;85:13–24
  9. Manolio TA, Rodriguez LL, Brooks L, Abecasis G, Ballinger D, Daly M, et al. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat. Genet. 2007;39:1045–1051
  10. O'Donovan MC, Craddock NJ, Owen MJ. Genetics of psychosis; insights from views across the genome. Hum. Genet. 2009;126:3–12
  11. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D, et al. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol. Psychiatry. 2010;advance online publication February 16, 2010
  12. Palha JA, Goodman AB. Thyroid hormones and retinoids: a possible link between genes and environment in schizophrenia. Brain Res. Rev. 2006;51:61–71
  13. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–752
  14. Rao ML, Kolsch H. Effects of estrogen on brain development and neuroprotection–implications for negative symptoms in schizophrenia. Psychoneuroendocrinology. 2003;28(Suppl 2):83–96
  15. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;460:753–757
  16. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744–747
  17. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-[alpha]. Nature. 2006;440:1054–1059
  18. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA. 2005;102:15545–15550
  19. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol. Psychiatry. 2008;13:570–584
  20. Sun J, Jia P, Fanous AH, Webb BT, van den Oord EJ, Chen X, et al. A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics. 2009;25:2595–2602
  21. Sun J, Jia P, Fanous AH, van den Oord EJCG, Chen X, Riley BP, et al. Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS ONE. 2010;5:e11351
  22. Tintle NL, Borchers B, Brown M, Bekmetjev A. Comparing gene set analysis methods on single-nucleotide polymorphism data from Genetic Analysis Workshop 16. BMC Proceedings. 2009;3(Suppl 7):S96
  23. Vivien D, Ali C. Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev. 2006;17:121–128
  24. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet. 2007;81:1278–1283

PII: S0920-9964(10)01380-0

doi: 10.1016/j.schres.2010.07.001

Schizophrenia Research
Volume 122, Issue 1 , Pages 38-42 , September 2010

Article Tools